Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy

Moise-Broder, Pamela A.; Sakoulas, George; Eliopoulos, George M.; Schentag, Jerome J.; Forrest, Alan; Moellering Jr., Robert C.
June 2004
Clinical Infectious Diseases;6/15/2004, Vol. 38 Issue 12, p1700
Academic Journal
We studied methicillin-resistant Staphylococcus aureus (MRSA) isolates to determine if the group II polymorphism at the accessory gene regulator (agr) locus demonstrated any relationship with the clinical efficacy of vancomycin. One hundred twenty-two MRSA isolates from 87 patients treated with vancomycin were evaluated. Forty-five of 87 patients had no clinical or bacteriological response to vancomycin. Among the 36 clinically evaluable patients with the agr group II polymorphism, 31 had an infection that failed to respond to vancomycin, whereas only 5 had an infection that responded successfully to vancomycin. This finding is of interest in light of our previous findings that glycopeptide-intermediately resistant S. aureus (GISA) and hetero-GISA clinical isolates in the United States and Japan are enriched for the agr group II polymorphism, and it suggests a possible intrinsic survival advantage of some S. aureus clones with this genetic marker under vancomycin selective pressure.


Related Articles

  • Methicillin-resistant Staphylococcus aureus enteritis in an immunologically uncompromised infant. Kimata, H.; Kawahara, M. // European Journal of Pediatrics;1999, Vol. 158 Issue 5, p431 

    Describes a case of methicillin-resistant staphylococcus aureus (MRSA) entiritis in a five-month-old girl, who had no immunodeficiency or prior surgery. How oral administration of vancomycin hydrochloride (VCM) improved enteritis and eradicated MRSA without any adverse effect; Description of MRSA.

  • New Perspectives on Fluoroquinolones.  // Review of Optometry;6/15/2007 Supplement, Vol. 144, p14A 

    The article offers perspective on fluoroquinolones. It focuses on the article titled "In Vitro of Fluoroquinolones, Vanocomycin and Gentamicin Against Methicilin-Resistant Staphylococcus aureus (MRSA) Ocular Isolates" which concludes that MRSA ocular isolates exhibited a relatively high rate of...

  • VANCOMYCIN DOSING FOR MRSA INFECTIONS. JOSEPH, WARREN S. // Clinical Advisor;Feb2012, Vol. 15 Issue 2, p61 

    A letter to the editor is presented in response to the article "Updated information on MRSA infections" in the December 2011 issue.

  • Alternative Mutational Pathways to Increased Vancomycin Resistance in MRSA. Seligman, Stephen J. // Journal of Infectious Diseases;Dec2013, Vol. 208 Issue 11, p1925 

    A letter to the editor is presented in response to an article related to alternative mutational pathways for generating intermediate resistance to vancomycin in methicillin resistant Staphylococcus aureus, which was published in a previous issue of the periodical.

  • Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant recipient. Matsubara, H.; Makimoto, A.; Higa, T.; Kawamoto, H.; Kanda, Y.; Kami, M.; Tanosaki, R.; Mineishi, S.; Ohira, M.; Takaue, Y. // Bone Marrow Transplantation;1/1/2003, Vol. 31 Issue 1, p65 

    Methicillin-resistant Staphylococcus aureus (MRSA) is a common infectious pathogen during stem cell transplantation. We report a case of meningoencephalitis with multiple abscess formation caused by MRSA, which occurred in a 4-year-old boy soon after allogeneic peripheral blood stem cell...

  • Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus. Vaudaux, P.; Ferry, T.; Uçkay, I.; François, P.; Schrenzel, J.; Harbarth, S.; Renzoni, A. // European Journal of Clinical Microbiology & Infectious Diseases;Dec2012, Vol. 31 Issue 12, p3367 

    We evaluated, by an improved susceptibility testing method, the prevalence and significance of low-level glycopeptide resistance in methicillin-resistant Staphylococcus aureus (MRSA) isolates, which belonged to a previously described, retrospective cohort of patients treated for orthopedic...

  • Superbugs are beating at the gates. Kmietowicz, Zosia // New Scientist;07/17/99, Vol. 163 Issue 2195, p22 

    Reports on strains of Staphylococcus aureus which are resistant to most conventional antibiotic drug treatments. Use of the unlicensed drug Synercid to kill the methicillin- resistant strain of S. aureus, which is also resistant to most other antibiotics; Mutations in the bacteria which render...

  • Vancomycin.  // Reactions Weekly;5/19/2012, Issue 1402, p43 

    The article describes the case of a 25-year-old man with a catheter-related methicillin-resistant staphyloccus infection who developed respiratory distress revealing Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome while receiving treatment with vancomycin.

  • Reduction in vancomycin susceptibility may occur in MSSA.  // Infectious Disease News;Nov2009, Vol. 22 Issue 11, p38 

    The article discusses a study that examined whether the evolution of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus is similar to that seen in methicillin-resistant Staphylococcus aureus.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics